[1]LAVANCHY D.The global burden of hepatitis C[J].Liver Int,2009,29(Suppl 1):74-81.
|
[2]FAWZY MM,WAHID A,NAZMY MH,et al.Association of interleukin-27 rs 153109 single nucleotide polymorphism with spontaneous resolution of hepatitis C virus-genotype 4a infection in egyptian patients[J].Asian Pac J Cancer Prev,2016,17(4):2093-2097.
|
[3]YANG Y,LIU H.Association between interleukin-18 gene promoter(-607C/A and-137G/C)polymorphisms and chronic hepatitis C virus infections:a meta-analysis[J].Meta Gene,2015,5:21-31.
|
[4]NADIA K,HICHAM E,REDA TM,et al.The complete title:The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C[J].Gene,2015,568(1):31-34.
|
[5]KAWAOKA T,HAYES CN,OHISHI W,et al.Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b[J].J Hepatol,2011,54(3):408-414.
|
[6]LIU C,JIANG J,GAO L,et al.A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China[J].Int J Genomics,2014,2014:247637.
|
[7]MAHMOUDI M,REZAIEMANESH A,SALMANINEJAD A,et al.PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus[J].Autoimmunity,2015,48(7):488-493.
|
[8]ZHANG G,LI N,ZHANG P,et al.PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated regionpolymorphism in patients with chronic HBV infection[J].Immunol Lett,2014,162(1 Pt A):212-216.
|
[9]SU SS,HE H,KONG LB,et al.Regulatory phenotype,PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy:a randomized clinical trial[J].PLo S One,2014,9(4):e93620.
|
[10]URBANI S,AMADEI B,TILA D,et al.Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection:effect of viremia levels and antiviral treatment[J].J Hepatol,2008,48(4):548-558.
|
[11]NAKAMOTO N,KAPLAN DE,COLECLOUGH J,et al.Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization[J].Gastroenterology,2008,134(7):1927-1937.
|
[12]XIAO W,JIANG LF,DENG XZ,et al.PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection[J].Immunol Res,2016,64(2):412-423.
|
[13]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol,2015,31(12):1961-1979.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1961-1979.
|
[14]ZHANG DD,YE PY,HUANG YX,et al.Analysis of predictive factors for rapid virologic response in treating patients with chronic hepatitis C[J].J Clin Hepatol,2014,30(12):1310-1314.(in Chinese)张丹丹,叶佩燕,黄玉仙,等.慢性丙型肝炎患者获得快速病毒学应答的预测因素分析[J].临床肝胆病杂志,2014,30(12):1310-1314.
|
[15]VIDAL-CASTINEIRA JR,LOPEZ-VAZQUEZ A,ALONSOARIAS R,et al.A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping[J].J Hepatol,2012,56(6):1230-1238.
|